Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
NVIDIA
NVDA
|
+$732M |
| 3 |
Amazon
AMZN
|
+$606M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
AT&T
T
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.41B |
| 2 |
Comcast
CMCSA
|
+$658M |
| 3 |
Boston Scientific
BSX
|
+$650M |
| 4 |
Palo Alto Networks
PANW
|
+$642M |
| 5 |
T-Mobile US
TMUS
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.81% |
| 2 | Healthcare | 2.95% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.15% |
| 5 | Industrials | 1.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10776
Phathom Pharmaceuticals
PHAT
$775M
| $105K | ﹤0.01% |
11,533
-264,194
| -96% | -$2.28M |
|
|
PMT
10777
PennyMac Mortgage Investment
PMT
$824M
| $105K | ﹤0.01% |
7,038
-197,117
| -97% | -$2.64M |
|
|
OPLN
10778
PUT
Openlane
OPLN
$4.33B
| $105K | ﹤0.01% |
7,100
-3,600
| -34% | -$52.3K |
|
|
DMC
10779
PUT
Del Monte Corp
DMC
$1.43B
| $105K | ﹤0.01% |
4,000
+2,100
| +111% | +$51.7K |
|
10780
PUT
Middlesex Water
MSEX
$1.11B
| $105K | ﹤0.01% |
1,600
+800
| +100% | +$52.7K |
|
10781
PUT
CrossAmerica Partners
CAPL
$901M
| $105K | ﹤0.01% |
4,600
-4,100
| -47% | -$90.9K |
|
10782
Smith Micro Software
SMSI
$16M
| $105K | ﹤0.01% |
3,173
-5,083
| -62% | -$189K |
|
10783
CALL
KT
KT
$9.11B
| $105K | ﹤0.01% |
+7,800
| New | +$99.9K |
|
10784
CALL
Puma Biotechnology
PBYI
$456M
| $105K | ﹤0.01% |
24,200
+23,800
| +5,950% | +$78.8K |
|
10785
CALL
Banco Bilbao Vizcaya Argentaria
BBVA
$158B
| $105K | ﹤0.01% |
11,500
+6,900
| +150% | +$59.3K |
|
|
GOCO
10786
DELISTED
GoHealth
GOCO
| $105K | ﹤0.01% |
7,841
+1,316
| +20% | +$18K |
|
|
AMED
10787
PUT
DELISTED
Amedisys
AMED
| $105K | ﹤0.01% |
1,100
+600
| +120% | +$56K |
|
10788
CALL
York Water
YORW
$541M
| $104K | ﹤0.01% |
2,700
+800
| +42% | +$30.1K |
|
10789
PUT
IRIDEX
IRIX
$14.9M
| $104K | ﹤0.01% |
37,100
+22,300
| +151% | +$58.5K |
|
10790
PUT
Direxion Daily MSCI Emerging Markets Bear 3X ETF
EDZ
$18.6M
| $104K | ﹤0.01% |
950
+440
| +86% | +$57.7K |
|
|
MORF
10791
PUT
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $104K | ﹤0.01% |
3,600
-5,100
| -59% | -$121K |
|
10792
PUT
Utz Brands
UTZ
$1.26B
| $104K | ﹤0.01% |
6,400
+3,100
| +94% | +$40.9K |
|
10793
CALL
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.79B
| $104K | ﹤0.01% |
+4,100
| New | +$100K |
|
|
YI
10794
111 Inc
YI
$32.3M
| $104K | ﹤0.01% |
6,706
+2,034
| +44% | +$42.4K |
|
10795
CALL
Wrap Technologies
WRAP
$105M
| $104K | ﹤0.01% |
33,500
+21,800
| +186% | +$49.7K |
|
10796
CALL
Immunome
IMNM
$3.09B
| $104K | ﹤0.01% |
9,700
+4,000
| +70% | +$33.3K |
|
|
LNKB
10797
DELISTED
LINKBANCORP
LNKB
| $104K | ﹤0.01% |
+12,999
| New | +$85.8K |
|
10798
CALL
Seres Therapeutics
MCRB
$45.6M
| $104K | ﹤0.01% |
3,700
+305
| +9% | +$8.01K |
|
10799
PUT
Sumitomo Mitsui Financial
SMFG
$167B
| $104K | ﹤0.01% |
10,700
-800
| -7% | -$7.75K |
|
10800
CALL
Gevo
GEVO
$418M
| $103K | ﹤0.01% |
89,200
-300
| -0.3% | -$342 |
|
Similar funds
Ken Griffin's Q4 2023 Portfolio in Review
As of Q4 2023, Ken Griffin held 15,795 positions worth $500B, up 7.2% from $467B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $25.4B in Q4 2023, closing 1,624 positions and reducing 6,315 holdings. Its most notable exit was Activision Blizzard, an estimated $1.41B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ken Griffin opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $129M.
- Ken Griffin's largest Q4 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,167,658 shares worth $129M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.38B increase.
- Ken Griffin's biggest Q4 2023 reduction was Comcast, cutting an estimated $658M.
- Ken Griffin fully exited Activision Blizzard in Q4 2023, selling an estimated $1.41B.
- Ken Griffin's ten largest holdings make up 31% of its $500B portfolio in Q4 2023.
- Ken Griffin opened 1,585 new positions and closed 1,624 in Q4 2023.
- Ken Griffin's portfolio value rose 7.2% quarter-over-quarter to $500B.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.